News

Published on 25 Feb 2024 on Simply Wall St. via Yahoo Finance

An Intrinsic Calculation For CSL Limited (ASX:CSL) Suggests It's 21% Undervalued


Article preview image

Key Insights

Using the 2 Stage Free Cash Flow to Equity, CSL fair value estimate is AU$362Current share price of AU$285 suggests CSL is potentially 21% undervalued The US$302 analyst price target for CSL is 17% less than our estimate of fair value

Today we'll do a simple run through of a valuation method used to estimate the attractiveness of CSL Limited (ASX:CSL) as an investment opportunity by taking the expected future cash flows and discounting them to today's value. Our analysis will employ the Discounted Cash Flow (DCF) model. Believe it or not, it's not too difficult to follow, as you'll see from our example!

ASX.CSL price evolution

Want to become a better investor?

Start tracking your investments with Statfolio

Sign up for free
Related News
Carlisle to Boost Product Portfolio With the Acquisition of ThermaFoam

Carlisle Companies Incorporated CSL recently announced that it has signed a definitive deal to...

Zacks · via Yahoo Finance 24 Dec 2024

Carlisle Buys Plasti-Fab & Enhances its Position in Polystyrene Market

Carlisle Companies Incorporated CSL recently completed the acquisition of the expanded polystyren...

Zacks · via Yahoo Finance 19 Dec 2024

Is It Too Late To Consider Buying Carlisle Companies Incorporated (NYSE:CSL)?

Carlisle Companies Incorporated (NYSE:CSL) saw a double-digit share price rise of over 10% in the...

Simply Wall St. · via Yahoo Finance 8 Dec 2024

EXEL vs. CSLLY: Which Stock Is the Better Value Option?

Investors interested in Medical - Biomedical and Genetics stocks are likely familiar with Exelixi...

Zacks · via Yahoo Finance 21 Nov 2024

Decoding Carlisle Companies Inc (CSL): A Strategic SWOT Insight

Robust Revenue Growth: CSL reports a significant increase in revenues, marking a strong financial...

GuruFocus.com · via Yahoo Finance 26 Oct 2024

GSK, Sanofi, And CSL Secure US Government Fund To Boost Bird Flu Vaccine...

The U.S. government has granted $72 million to European pharma giants GSK Plc (NYSE:GSK), Sanofi ...

Benzinga · via Yahoo Finance 5 Oct 2024

Arcturus Therapeutics/CSL Partnered COVID-19 Vaccine Surpasses Pfizer's...

Arcturus Therapeutics/CSL Partnered COVID-19 Vaccine Surpasses Pfizer's Comirnaty Shot, Even At L...

Benzinga · via Yahoo Finance 30 Sep 2024

Arcturus Therapeutics/CSL Partnered COVID-19 Vaccine Surpasses Pfizer's...

CSL Limited (OTC:CSLLY) and Arcturus Therapeutics (NASDAQ:ARCT) announced the results of a Phase ...

Benzinga · via AOL 30 Sep 2024

Does Carlisle Companies Incorporated (CSL)’s Strong Financial Performance Make...

We recently compiled a list of the 9 Best Plastics and Rubber Stocks to Buy. In this article, we ...

Insider Monkey · via Yahoo Finance 20 Jun 2024

Here's Why You Should Add Carlisle (CSL) to Your Portfolio

Carlisle Companies Incorporated CSL is well poised for growth, courtesy of strength across its bu...

Zacks via Yahoo Finance 31 May 2024